Skip to main content

Want a detailed portfolio tracker?

Ionis Pharmaceuticals (IONS) P/E (2010 - 2026)

Ionis Pharmaceuticals (IONS) P/E from Mar 31, 2010 to Jul 21, 2026. The TTM Ionis Pharmaceuticals (IONS) P/E is -50.67. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Ionis Pharmaceuticals (IONS)

YearP/EChange
2026-50.67-9.06%
2025-55.71+22.75%
2024-45.39+19.54%
2023-37.97-286.16%
202220.40+6.46%
202119.16-207.38%
2020-17.84-158.61%
201930.44+11.60%
201827.28-80.36%
2017138.92-542.77%
2016-31.37-93.39%
2015-474.76+155.87%
2014-185.55+144.59%
2013-75.86+371.95%
2012-16.07+76.24%
2011-9.12-44.34%
2010-16.39N/A

Comparison Ionis Pharmaceuticals (IONS) P/E with competitors

Ionis Pharmaceuticals (IONS) P/E is -50.67.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.00%
NBYStablecoin Development Corp0.00-100.01%
ENLVEnlivex Ltd0.07-100.15%
FGENFibroGen Inc0.24-100.47%
CHRSCoherus Biosciences Inc0.85-101.67%
FBIOFortress Biotech Inc0.95-101.87%
ORMPOramed Pharmaceuticals Inc1.50-102.97%
AGENAgenus Inc3.01-105.94%
INVAInnoviva Inc3.15-106.22%
VXRTVaxart Inc3.55-107.01%
CRMDCorMedix Inc3.63-107.16%
CVACCureVac N.V.4.45-108.77%
GLPGGalapagos NV4.86-109.59%
SRPTSarepta Therapeutics Inc4.88-109.64%
ABEOAbeona Therapeutics Inc5.39-110.63%
ABUSArbutus Biopharma Corp5.60-111.04%
ZVRAZevra Therapeutics Inc5.89-111.62%
SPROSpero Therapeutics Inc6.23-112.29%
CGENCompugen Ltd6.31-112.46%
RIGLRigel Pharmaceuticals6.87-113.56%
SLXNSilexion Therapeutics Corp7.30-114.40%
OMEROmeros Corporation9.26-118.27%
AUPHAurinia Pharmaceuticals Inc9.58-118.92%
PLXProtalix BioTherapeutics Inc10.89-121.49%
ACADAcadia Pharmaceuticals Inc11.73-123.15%
TBPHTheravance Biopharma Inc12.26-124.20%
ADMAAdma Biologics Inc12.42-124.51%
HRMYHarmony Biosciences Holdings Inc13.82-127.28%
SABSSAB Biotherapeutics Inc14.14-127.90%
NAGENiagen Bioscience Inc14.82-129.25%
INCYIncyte Corp15.82-131.23%
REGNRegeneron Pharmaceuticals Inc15.86-131.29%
PBYIPuma Biotechnology Inc17.32-134.17%
CPRXCatalyst Pharmaceuticals Inc17.44-134.42%
EXELExelixis Inc17.54-134.61%
TGTXTG Therapeutics Inc18.97-137.43%
MDXGMimedx Group Inc20.55-140.56%
XOMAXOMA Royalty Corp22.87-145.15%
ARGXArgen X SE24.30-147.96%
CTMXCytomX Therapeutics Inc24.82-148.99%
XOMAOXOMA Royalty Corp25.34-150.02%
HALOHalozyme Therapeutics Inc25.62-150.57%
XOMAPXOMA Royalty Corp25.67-150.66%
VRTXVertex Pharmaceuticals Inc27.99-155.25%
RPRXRoyalty Pharma plc - Class A28.69-156.62%
SLNOSoleno Therapeutics Inc29.02-157.27%
ASNDAscendis Pharma A/S30.09-159.38%
LGNDLigand Pharmaceuticals Inc - Class B37.91-174.83%
APLSApellis Pharmaceuticals Inc39.02-177.02%
BMRNBiomarin Pharmaceutical Inc42.21-183.31%
KRYSKrystal Biotech Inc45.34-189.49%
ONCBeiGene Ltd69.54-237.25%
PHARPharming Group N.V.75.03-248.08%
TECHBio-Techne Corp101.96-301.23%
VCELVericel Corp109.92-316.95%
ALNYAlnylam Pharmaceuticals Inc117.96-332.82%
GMABGenmab140.29-376.89%
TLXTelix Pharmaceuticals Ltd162.15-420.04%
CORTCorcept Therapeutics Inc212.86-520.11%